BIOLASE Technology, Inc. Announces FDA Clearance Of Its ezlase(TM) Soft Tissue Diode Laser

IRVINE, CA -- (MARKET WIRE) -- January 31, 2007 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market ezlaseā„¢, a new soft tissue diode laser system (patents pending).

Back to news